<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2013</study_start_year><condition>Colorectal Cancer</condition><disease>Colorectal Cancer</disease><study_type>Observational</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2626332</full_dataset_link><location>Japan</location><study_start_month>6</study_start_month><repository>ECRIN MDR</repository><study_status>Completed</study_status></additional><is_claimable>false</is_claimable><name>Multicenter prospective observation study of salvage-line bevacizumab for unresectablemetastatic colorectal cancer in Okayama</name><description>Primary outcome(s): PFS; progression-free survival</description><dates><creation>2013-06-15</creation></dates><accession>2626332</accession><cross_references><Japan Primary Registries Network>JPRN-UMIN000010955</Japan Primary Registries Network></cross_references></HashMap>